April 20, 2026 a 06:00 pm
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs. With a solid presence in multiple regions, it caters to biologic, generic, and pharmaceutical drug companies. The company's innovative solutions are crucial for safe and effective drug delivery, making it a vital player in the healthcare sector.
Fundamental Rating
West Pharmaceutical Services, Inc. maintains a consistent fundamental performance with specific strengths and weaknesses in various categories.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The historical scores provide insight into the company's performance over time.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-20 | 3 | 3 | 4 | 5 | 2 | 2 | 1 |
| N/A | 0 | 3 | 4 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Analyst price targets reflect optimism for WST, with a varied range of projections.
| High | Low | Median | Consensus |
|---|---|---|---|
| 340 | 265 | 305 | 303.33 |
Analyst Sentiment
The current analyst sentiment shows a strong inclination towards buying, despite a few sells.
| Recommendation | Number | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. demonstrates robust fundamental metrics, especially in Return on Assets and Equity, suggesting efficient management and profitability. Although there are concerns regarding their debt levels, overall, the company is favorably viewed by analysts, and the future price targets lean towards potential growth. However, economic fluctuations and industry-specific challenges could influence its performance. Continued innovation and market expansion remain key growth drivers.